Ventas Inc. (VTR), a real estate investment trust focused on healthcare properties, saw its stock soar 7.96% in Thursday's intraday trading session, following the company's impressive fourth-quarter 2024 results and positive outlook for 2025.
The healthcare REIT reported normalized funds from operations (FFO) per share of $0.81 for Q4 2024, beating analysts' estimates by a penny and marking a 6.6% year-over-year increase. Revenues of $1.29 billion also surpassed expectations and grew 10.5% compared to the same period last year.
A significant driver of Ventas' strong performance was the robust growth in same-store cash net operating income (NOI), which climbed 8.4% for the company's total portfolio. Notably, the Senior Housing Operating Portfolio (SHOP) segment saw a remarkable 16.9% increase in same-store cash NOI, fueled by higher average occupancy rates and revenue per occupied room.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.